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Abstract
Lacrimal gland inflammation during autoimmune Sjögren’s syndrome (SS) leads to ocular surface inflammation –
Keratoconjunctivitis sicca (KCS). This condition afflicts both the cornea and conjunctiva that form the ocular surface.
Thrombospondin-1 (TSP-1) deficiency in mice results in lacrimal gland and corneal inflammation that resembles the
human disease. In this study we report conjunctival pathology in this mouse model of SS. We found that TSP-1 null
mice develop inflammation in the conjunctiva and associated loss of goblet cell function similar to that seen in
patients with SS. Increased expression of Th1 (IFN-γ, TNF-α) and Th17 (IL-6, IL-17A) inflammatory cytokines and
related transcription factors (Tbet and RORγt) were detected in TSP-1 null conjunctiva as well as their draining lymph
nodes (LNs). The conjunctival inflammation was also accompanied by an increase in local lymphatic vessels.
Interestingly, migration of antigen-bearing dendritic cells (DCs) from the ocular surface to the LNs was dependent on
the TSP-1 available in the tissue. These results not only reveal potential immunopathogenic mechanisms underlying
KCS in SS but also highlight the therapeutic potential of TSP-1.
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Introduction
Sjögren’s syndrome (SS) is the second most common
autoimmune rheumatic disease and afflicts an estimated 2-4
million individuals in the United States [1]. It is an autoimmune
exocrinopathy involving chronic inflammation and progressive
functional loss of exocrine glands – salivary and lacrimal
glands. The secretory deficit of these glands consequently
affects the target organ protected by their secretions resulting
in clinical manifestations of xerostomia (dry mouth) and
xerophthalmia (dry eye). The latter condition is also referred to
as Keratoconjunctivitis sicca (KCS) indicating the dryness and
inflammation of the cornea and conjunctiva of the eye that form
the ocular surface. Patients with Sjögren’s syndrome are
reported to develop inflammatory infiltrates in the salivary and
lacrimal glands [2], a pathology that is well reproduced in mice
known to develop the disease spontaneously [3-5]. Pathologic
changes are also detectable in the conjunctiva of patients with
Sjögren’s syndrome [6-8], however these are not yet reported
in any of the mice with this disease. An animal model that
recapitulates most pathologic features of the disease can serve
as a useful tool not only to reveal underlying mechanisms but
also to develop comprehensive therapeutic approaches that
target multiple pathologic aspects of the disease.
We have previously reported spontaneous development of
autoimmune SS-associated ocular phenotype in
thrombospondin-1 (TSP-1) deficient mice that closely
resembles human disease [9]. As seen in Sjögren’s patients
these mice develop KCS progressively with age, which
coincides with a secretory deficit of lacrimal glands and altered
tear composition resulting in a gradual loss of corneal barrier
function. Moreover anti-SSA and anti-SSB autoantibodies that
develop in Sjögren’s patients are also detectable in TSP-1
deficient mice. Thus, to our knowledge, these mice represent
the only mouse model in which chronic development of ocular
surface inflammation associated with autoimmune SS is
reported.
Thrombospondin-1 is a platelet derived glycoprotein that is
also expressed by other cell types including epithelial cells of
the ocular tissues [10,11]. Besides its ability to activate latent
TGF-β [12], TSP-1 is reported to be involved in regulation of
vascular and lymphatic angiogenesis [13]. It has been
described to have an immunoregulatory function with anti-
inflammatory effects on antigen presenting cells and immune
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effector T cells [14-17]. We have reported previously that
expression of TSP-1 is critical for the ocular immune privilege
that protects ocular tissues from sight threatening inflammatory
damage [18]. The immunomodulation induced by ocular
antigen presenting cells is dependent on their expression of
TSP-1 [19]. Consistent with these reports a significant decline
in the splenic population of regulatory T cells is observed in
TSP-1 deficient mice [9] indicative of failure of peripheral
immune tolerance, which presumably contributes to the
autoimmunity in these mice. Similar to Sjögren’s syndrome in
human patients [20], the autoimmune response in TSP-1
deficient mice targets the lacrimal gland resulting in infiltration
with Th1 and Th17 inflammatory subsets associated with
autoimmune diseases. Infiltration of the conjunctiva by T cells
was reported in human subjects diagnosed with KCS [21].
However, unlike lacrimal gland infiltrates, any subset of T cells
in conjunctival infiltrates still remain to be characterized. None
of the currently available SS mouse models have reported
conjunctival pathology.
In this study we now report that the inflammation in the
conjunctiva is involved in the KCS present in the TSP-1
deficient mouse model of SS, which potentially disrupts the
secretory function of goblet cells further compromising the
protective function of tears and contributing to ocular surface
damage. We evaluated the temporal association of conjunctival
inflammation with the inflammatory effectors in the draining
lymph nodes of TSP-1 null mice. Our results suggest that
enhanced migration of ocular surface antigen presenting cells
(APCs) to draining lymph nodes, in TSP-1null mice, potentially
contributes to the induction of immune response against
antigens derived from the ocular surface. Moreover, TSP-1 was
found to regulate expression of a lymph node homing receptor,
CCR7, on dendritic cells (DC) and successfully blocked DC
migration to draining lymph nodes when injected
subconjuctivally in TSP-1 deficient mice. Thus our results
demonstrate that TSP-1null mice mimic conjunctival
manifestations of autoimmune Sjögren’s syndrome and reveal
a potential immunopathogenic mechanism to be targeted by
new therapeutic approaches to help prevent progression of the
disease.
Materials and Methods
Ethics Statement
All animal experiments were conducted in accordance with
institutional guidelines. The protocol (S-249-0912) was
approved by the Institutional Animal Care and Use Committee
(IACUC) at Schepens Eye Research Institute. All efforts were
made to minimize suffering including the use of
ketamine:xylazine anesthesia administered prior to performing
s.c. injections.
Mice
C57BL/6 (H-2b) mice, 4 to 12 weeks old, were purchased
from Charles River Laboratories (Wilmington, MA). TSP-1 null
mice (C57BL/6 background), originally received from Dr. J.
Lawler (BIDMC, Harvard Medical School, Boston, MA) were
bred in-house in a pathogen-free facility at Schepens Eye
Research Institute, Boston, MA.
Histology
Lacrimal glands or whole eyes and lids were harvested and
fixed immediately in 4% paraformaldehyde and embedded in
methacrylate. Sections (6 to 8 µm) were cut and stained with
H&E. For the sections of the conjunctiva we used sagittal
sections from the middle of the eye as representative of the
whole conjunctiva to control for the variations in goblet cell
density over the surface of the eye. Both the bulbar and
palpebral conjunctiva were examined on three slides with five
serial sections each.
Immunohistochemistry
TSP-1 null and WT C57BL/6 mice were euthanized at 8 or
12 weeks of age. The conjunctivas were harvested, rinsed in
PBS, fixed in acetone and washed in PBS. Then the tissue was
incubated in EDTA and rinsed in PBS again. After blocking with
BSA conjunctival flat mounts were incubated in anti-LYVE-1
antibody (AngioBio, Del Mar, CA) overnight. The next day the
tissue was washed, blocked and incubated with a Cy3-
conjugated secondary antibody (Jackson ImmunoResearch,
West Grove, PA). After rinsing in PBS the tissue was incubated
in Alexa488-conjugated CD11b antibody (BD Biosciences, San
Jose, CA). Then the flat mounts were washed in PBS,
transferred to glass slides, coverslipped with mounting medium
and stored at 4°C prior to analysis with a fluorescence
microscope. Three pictures were randomly taken of each flat
mount with a fluorescence microscope, the LYVE-1 and CD11b
positive cells were counted manually and the percentage of the
Lyve-1+ / CD11b+ cells to all CD11b+ cells was calculated.
ELISA
Pilocarpine-induced tears in some experiments were
measured for their levels of MUC5AC content using an ELISA
kit (TSZ ELISA, Waltham, MA). The assay was performed
according to the manufacturer’s instructions.
Real-time PCR
Total RNA was isolated from the conjunctiva or cervical
lymph nodes harvested from WT or TSP-1 null mice using RNA
STAT-60 (Tel-Test, Inc., Friendswood, TX) according to the
manufacturer’s instructions. cDNA was synthesized by reverse
transcribing RNA using oligo dT and M-MLV RT (Promega,
Madison, WI). SYBR green real-time PCR assay was used to
determine relative quantitative expression of selected genes.
Sequences of the primers used for these genes are as follows:
glyceraldehyde-3-phosphate dehydrogenase, F-5’-
CGAGAATGGGAAGCTTGTCA-3’, R-5’-
AGACACCAGTAGACTCCACGACAT-3’. Interferon-gamma,
F-5’-TCAGCAACAACATAAGCGTCAT-3’, R-5’-
GACCTCAAACTTGGCAATACTCAT-3’, Interleukin-6, F-5’-
AGTCAATTCCAGAAACCGCTATGA-3’, R-5’-
TAGGGAAGGCCGTGGTTGT-3’, Interleukin-17A, F-5’-
AGTGAAGGCAGCAGCGATCAT-3’, R-5’-
CGCCAAGGGAGTTAAAG-3’, RORγt, F-5’-
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TCAAGTTTGGCCGAATGTC-3’, R-5’-
CATCTGAGAGCCCTAAAGTGTATG-3’, Tbet, F-5’-
CGCATCTGTTGATACGAGTGT-3’, R-5’-
GCTGGGAACAGGATACTG-3’, FoxP3, F-5’-
GGAGAGGCAGAGGACACTCAAT-3’, R-5’-
GTGGTTTCTGAAGTAGGCGAACAT-3’, MUC5AC, F-5’-
CCAACTCCAGCCATATCGT -3’, R-5’-
CAGGGTAACTGCCATCTAGC -3’. Amplification reactions
were set up using KAPA SYBR FAST mastermix (KAPA
Biosystems, Woburn, MA) in triplicates with the thermal profile:
1 cycle of 95°C for 5 min; 40 cycles of [95°C for 10 seconds,
52°C to 55°C for 10 seconds, 72°C for 10 seconds] on an
Eppendorf Realplex2 (Eppendorf AG, Hamburg, Germany).
Fluorescence signal generated at each cycle was analyzed
using system software. The threshold cycle values were used
to determine relative quantitation of gene expression with
glyceraldehyde-3-phosphate dehydrogenase as a reference
gene.
Draining of ocular surface antigen to cervical lymph
nodes
Two groups of TSP-1 null mice (n=3 each) received either a
subconjunctival injection of 10 µl TSP-1 (Haematologic
Technologies, Essex Junction, VT) in PBS (50 ng/10 µl, per
eye) or PBS alone (10 µl per eye). A control group of WT mice
received no injections. A day after subconjunctival injections all
mice received eye drops containing Alexa647-conjugated
Ovalbumin (Life Technologies, Carlsbad, CA) in PBS (250 µg/5
µl per mouse, 2.5 µl per eye). After 3 h all the mice were
sacrificed and their cervical lymph nodes (CLNs) were
collected. The CLNs in each group were pooled, filtered
through a 70µm nylon mesh, and the resulting single-cell
suspensions were washed and resuspended in cold PBS
containing 0.1% bovine serum albumin. Cells from CLNs were
stained with eFluor 780-conjugated Fixable Viability Dye
(eBioscience, San Diego, CA) and fluorescence labeled anti-
CD11c (BD Biosciences, San Jose, CA).
Flow cytometry
Dendritic cells were generated by culturing bone marrow
cells (10 x 106) with granulocyte-macrophage colony-
stimulating factor (GM-CSF) (20 ng/ml, Biolegend, San Diego,
CA) in a petri dish for 7 days. The medium in these cultures
was replenished every 2 days. Bone marrow derived dendritic
cells (BMDCs) were treated with TSP-1 (1 µg/ml, Hematologic
Technologies, Inc., VT) for 24 h before staining with
fluorescence labeled anti-CCR7 antibody (eBioscience, San
Diego, CA). Fluorescence-labeled cells were analyzed using a
BD LSR II flow cytometer (BD Biosciences, San Jose, CA).
Further analysis of the data was performed using FlowJo
software.
Statistical Analysis
Student’s unpaired t-test was used to determine significant
differences between mean values of experimental and control
groups. Error bars in figures represent + SEM and p < 0.05
was considered statistically significant.
Results
Inflammatory damage is detectable in TSP-1 null
conjunctiva
Deficiency of TSP-1 was previously reported to result in an
appearance of inflammatory infiltrate in the lacrimal gland [9].
Such infiltration was detected at 24 weeks of age while no
significant inflammatory cells were detectable in the lacrimal
gland histology of younger animals. To determine if ocular
inflammation in TSP-1 deficient mice is associated with any
inflammatory damage in the conjunctiva we examined
conjunctiva histology. Tissues sections stained with H&E were
compared at different ages.
As shown in Figure 1A, at 6 weeks of age TSP-1 null
conjunctiva was comparable to that in WT control and showed
normal cell layers and morphology with abundant conjunctival
epithelial goblet cells and a complete lack of abnormal
inflammatory cells. However, at 12 weeks, TSP-1 null
conjunctiva displayed a marked thickening of the outer
epithelial layers, a relative decrease in goblet cell numbers and
a prominent infiltration of inflammatory cells, while no such
alterations were detectable in WT conjunctiva.
These results suggest that ocular inflammation in TSP-1 null
mice involves inflammatory damage of the conjunctiva and that
this damage is histologically detectable at 12 weeks of age.
Thus inflammatory changes in the conjunctiva in TSP-1 null
mice appear to precede those reported in their lacrimal glands.
Tear mucin levels are diminished in TSP-1 null mice
Mucins are an important and protective component of tears.
While both the membrane bound and soluble forms of mucins
are produced by epithelial cells in the conjunctiva, a gel-
forming soluble mucin MUC5AC is secreted by goblet cells in
the conjunctiva. To determine whether the histopathological
finding in TSP-1 null conjunctiva was associated with secretory
impairment of goblet cells, we assessed changes in levels of
MUC5AC in pilocarpine-induced tears and its message in
conjunctiva, with age.
As seen in Figure 1B, a significant decrease in the MUC5AC
content of tears was detected at 12, 8, and 6-week-old TSP-1
deficient mice compared to their age-matched WT controls.
However, no significant differences were detected at 4 weeks
of age. These changes matched those detected in the
MUC5AC message level (Figure 1C). It is to be noted that tear
MUC5AC levels progressively decreased with age in TSP-1
null mice.
Therefore these results suggest that the secretory function of
goblet cells in the conjunctiva, despite appearing normal at 4
weeks, becomes progressively deficient with age in the
absence of TSP-1. The functional loss of goblet cells in TSP-1
null mice precedes the histopathology detected.
Inflammatory cytokines are detectable in TSP-1 null
conjunctiva in the absence of apparent inflammatory
infiltrates
Although the presence of inflammatory infiltrate in the target
tissue is considered a primary immunopathogenic indicator, the
microscopic exam of tissue histology limits detection of early
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Figure 1.  Inflammatory damage and diminished mucin levels are detectable in TSP-1 null conjunctiva.  (A) Histology of
conjunctiva from WT and TSP-1 null mice at 6 and 12 weeks. Representative hematoxylin-eosin stained sections at 6 weeks show
normal epithelial morphology and a lack of abnormal inflammatory cells. At 12 weeks, TSP-1 null conjunctiva displayed prominent
inflammatory infiltrates (arrows) in the epithelial layer adjacent to goblet cells. (B-C) Pilocarpine-induced tears and conjunctival
tissues collected from WT or TSP-1 null mice (n=5 each) were analyzed for levels of MUC5AC using ELISA and real time PCR,
respectively. At 6, 8, and 12 weeks of age, goblet cell-derived tear mucin content and conjunctival message were significantly
diminished in TSP-1 null mice compared to age-matched controls, while no significant differences were detected at 4 weeks of age.
Results are presented as ng/ml for ELISA assay and as relative expression to that of housekeeping gene GAPDH for real time PCR
(*p < 0.05 compared to WT control; #p < 0.05 compared to 4 weeks).
doi: 10.1371/journal.pone.0075937.g001
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changes that lead to the infiltration. Assessing changes in the
expression of inflammatory cytokines by real-time PCR allows
detection of changes prior to the appearance of infiltrates. Thus
in TSP-1 deficient mice increased levels of inflammatory
cytokines were detectable in lacrimal glands long before the
inflammatory infiltrates were detectable [9]. Considering that
the secretory changes in conjunctival goblet cells begin prior to
the detection of infiltrates, we performed real-time PCR
analysis on the RNA isolated from WT or TSP-1 null
conjunctiva to study expression levels of dry eye-associated
inflammatory cytokines.
Significant over expression of Th1 (TNF-α, IFN-γ) and Th17
(IL-6 and IL-17A) cytokines was detected in TSP-1 null
conjunctiva harvested from 6, 8, and 12 week old mice
compared to the age-matched WT control tissue. The over
expression of all studied cytokines progressively increased with
the age of the mice (Figure 2).
Our findings suggest that TSP-1 deficiency in mice results in
inflammatory damage of the conjunctiva as reported in patients
with KCS associated with SS [22,23]. Moreover, our results
also indicate that the inflammatory changes begin as early as 6
weeks, and are gradually aggravated with age. These changes
Figure 2.  Inflammatory cytokines are detectable in TSP-1 null conjunctiva in the absence of apparent inflammatory
infiltrates.  Conjunctiva tissue from WT and TSP-1 null mice was harvested at 6, 8, and 12 weeks (n=3 each) to isolate RNA, which
was analyzed using a SYBR Green real-time PCR assay to determine levels of INF-γ (A), TNF-α (B), IL-6 (C) and IL-17A (D).
Significantly increased expression of Th1 (TNF-α, IFN-γ) and Th17 (IL-6 and IL-17A) cytokines was detected in TSP-1 null
conjunctiva at all tested ages, compared to their age-matched WT control tissue. The expression of all studied cytokines
progressively increased with age. Results are presented as relative expression of a cytokine gene to that of housekeeping gene
GAPDH (*p < 0.05 as compared to WT controls)..
doi: 10.1371/journal.pone.0075937.g002
Conjunctival Inflammation in Sjögren's Mouse Model
PLOS ONE | www.plosone.org 5 September 2013 | Volume 8 | Issue 9 | e75937
appear to coincide with the loss of MUC5AC secretion by
conjunctival goblet cells.
TSP-1 deficiency results in increased lymphatic vessels
in the conjunctiva
Lymphatic vessels play an important role in any disease
immunopathogenesis, providing a potential route by which
tissue antigen presenting cells (APCs) can introduce tissue–
derived antigens into the draining lymph nodes. In an otherwise
avascular tissue such as cornea the association of
lymphangiogenesis with inflammation has been reported and
TSP-1 is known to inhibit such inflammatory
lymphangiogenesis [13]. In addition, it has been previously
described that during corneal inflammation an increase in
lymphatic vessels corresponds to a decline in the conjunctival
population of LYVE-1 expressing monocytic cells suggesting
such cells to be a reservoir for lymphangiogenic cells [24].
Thus the number of LYVE-1+ monocytic cells can be an indirect
measure of lymphatic vessel density. To examine whether
TSP-1 deficiency is associated with changes in conjunctival
lymphangiogenesis, we first evaluated lymphatic vessels by
histology and then by enumerating LYVE-1 expressing
monocytic cells by immunoflourescence studies.
As shown in Figure 3A, unlike blood vessels lymphatic
vessels are discerned as vessels with thin endothelial walls
and are devoid of blood cells. We detected relatively increased
lymphatic vessels in H&E stained sections of TSP-1 null
conjunctiva at 12 weeks (but not at 8 weeks), compared with
the age-matched WT control tissue. To determine if this
increase is reflected in a decline in LYVE-1 expressing
monocytic cells we stained conjunctiva tissue and enumerated
LIVE-1+ CD11b+ monocytic cells in WT and TSP-1 null
conjunctiva, at both 8 and 12 weeks (Figure 3B). Quantitative
analysis of immunofluorescence staining at these two ages
demonstrated a greater decline in LYVE-1 expressing CD11b+
cells in TSP-1 null mice at 12 weeks, as compared to WT mice
(Figure 3C). Thus our results support the histological
observations in TSP-1 null conjunctiva indicating an increase in
lymphatic vessels.
The development of inflammatory effectors in the
draining lymph nodes of TSP-1 null mice coincides with
the increased lymphatic vessels
Resident APCs in any tissue, such as dendritic cells (DCs),
are known to migrate via lymphatic vessels to the local draining
lymph nodes where they present antigens to generate
activated effector T cells. In an autoimmune disease such
APCs are known to generate effectors that subsequently target
the tissue. Both Th1 and Th17 represent inflammatory subsets
of T effector cells that are associated with autoimmune
responses in SS [25]. We next sought to determine the
presence of such effectors in the CLN of WT or TSP-1 null
mice as well as the target tissue.
Real-time PCR analysis using RNA isolated from WT or
TSP-1 null CLN and conjunctiva was performed at 6, 8 and 12
weeks of age to assess expression levels of transcription
factors Tbet (Th1) and RORγt (Th17). As shown in Figure 4, at
6 weeks of age no differences in Tbet or RORγt expression
were detectable between WT and TSP-1 null mice in either
conjunctiva or CLN. However, in 8 and 12 week old TSP-1 null
mice the expression of both transcription factors was
significantly increased in both conjunctiva and CLN as
compared with the WT control tissues. Also expression levels
of both Tbet and RORγt progressively increased with the age
of mice.
Additionally we evaluated the expression of Foxp3 (Treg) in
the CLN to determine if changes in this regulatory subset
correspond to those in the inflammatory subsets. The
expression of Foxp3 was significantly diminished in TSP-1 null
CLN at 12 weeks of age. This observation is consistent with the
previously reported reduced numbers of Foxp3+ Tregs in the
spleen in TSP-1 null mice [9]. Together our results suggest that
in TSP-1 null mice a peripheral imbalance in inflammatory and
Treg cells results in the development of increased inflammatory
effectors between 8 and 12 weeks that subsequently target the
conjunctiva.
Migration of dendritic cells carrying ocular surface
antigens to the draining lymph nodes is enhanced in
TSP-1 null mice
Antigen-presenting DCs are positioned as sentinels in the
ocular surface, capturing foreign antigens. Under inflammatory
conditions, DCs undergo a process called maturation, and
readily relocate to CLN to stimulate the differentiation of naïve
T cells into effectors cells [26]. Previously TSP-1 was reported
to prevent maturation of DC [16], including corneal DCs [27].
Additionally, the expression of CCR7, a key molecule in DC
trafficking to draining lymph nodes that is upregulated in
mature DCs [28], was also reported as increased in TSP-1
deficient DCs [27]. These observations suggest an increased
potential of ocular surface DCs in TSP-1 null mice to migrate to
the draining lymph node. Such a possibility may then explain
the increased levels of inflammatory effectors detected in
TSP-1 null lymph nodes compared to their age-matched WT
controls.
To address this possibility we assessed the migration of
resident TSP-1 null DCs carrying an antigen from the ocular
surface to the CLN. We instilled Alexa-647-conjugated
ovalbumin (OVA) as an antigen in the eyes of TSP-1 null and
WT mice. Antigen-laden DCs (Alexa647+ CD11c+) migrating to
the CLN were identified by flow cytometry. A significant
increase in DCs was detected in TSP-1 null mice compared to
WT controls (Figure 5A). These data clearly indicated an
enhanced DC migration to the LN in TSP-1 null mice.
To determine if TSP-1 directly regulated CCR7 expression,
we used bone marrow derived dendritic cells from WT mice
and treated them in vitro with TSP-1 for 24 h and assessed
their CCR7 expression by flow cytometry. We found that TSP-1
treatment significantly decreased the expression of CCR7
(Figure 5C). Based on these results we next determined if
TSP-1 could block DC migration from TSP-1 null conjunctiva.
We injected TSP-1 or PBS subconjunctivally before the
application of Alexa-647-conjugated OVA to the ocular surface
of TSP-1 null mice. Appearance of OVA-laden DCs was
evaluated in the CLN. As shown in Figure 5B, a blockade of
Alexa647+ CD11c+ DC migration to CLN was observed in
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TSP-1 null mice following TSP-1 injection as compared to PBS
injection in the control group. Taken together, these data
suggest that TSP-1 regulates DC migration from the ocular
surface to the LN by regulating their expression of CCR7.
Discussion
Ocular surface inflammation in TSP-1 deficient mice is
associated with autoimmune SS and remarkably resembles
histopathological and serological changes detectable in SS
Figure 3.  Increased lymphatic vessels in TSP-1 null conjunctiva are accompanied by a decline in LYVE-1+
macrophages.  (A) Hematoxylin and eosin stained sections of the conjunctiva harvested from 12 week old WT or TSP-1 null mice
show relatively increased lymphatic vessels in TSP-1 null conjunctiva. (B) Whole mounts of conjunctiva from 8 and 12 week old WT
and TSP-1 null mice were immunostained with fluorochrome conjugated anti-LYVE-1(red) and anti-CD11b (green) antibodies. (C)
Quantitative analysis of positively stained cells showed significantly increased decline in LYVE-1 expressing CD11b+ macrophages
at 12 week (from 8 week) of age in TSP-1 null mice as compared to WT mice (* p < 0.05, compared to WT)..
doi: 10.1371/journal.pone.0075937.g003
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Figure 4.  Inflammatory effectors are detected in the conjunctiva and the draining lymph nodes of TSP-1 null
mice.  Conjunctiva tissue and cervical lymph node cells were collected from WT and TSP-1 null mice at 6, 8, and 12 weeks (n=3
each). Extracted RNA was analyzed in a real-time PCR assay to determine the levels of message for the transcription factors Tbet,
RORγt and Foxp3. No significant differences were detected in Tbet or RORγt expression in conjunctiva (A) and lymph nodes (B) at
6 weeks of age, while at 8 and 12 weeks the expression of both transcription factors was significantly increased in TSP-1 null mice
compared with the WT control tissues. Expression of Foxp3 was significantly decreased in TSP-1 null lymph nodes at 12 weeks of
age. Results are presented as relative expression of a transcription factor gene to that of the housekeeping gene GAPDH (* p <0.05
as compared to WT controls)..
doi: 10.1371/journal.pone.0075937.g004
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Figure 5.  Migration of DCs carrying ocular surface antigens to draining LNs is enhanced in TSP-1 null mice.  Cervical lymph
nodes from 10-week old WT and TSP-1 null mice (n=3 each) were harvested 3 hr after topical application of Alexa647-conjugated
OVA (125 µg/2.5 µl per eye). Lymph node cells were stained with fluorochrome-conjugated CD11c prior to analysis by flow
cytometry and CD11c/Alexa647+ cells were identified. (A) A marked increase in CD11c/Alexa647+ cells was detectable in TSP-1 null
lymph node cells compared to WT controls. (B) Blockade of CD11c/Alexa647+ dendritic cell migration to draining lymph nodes was
observed in TSP-1 null mice following subconjunctival (S.C) injection of TSP-1 as compared to PBS-injected control group. (C)
BMDC were treated with TSP-1 for 24 hr, stained with fluorochrome-conjugated CCR7, and analyzed by flow cytometry. The
histogram shows fluorescence detected in unstained (thin line), untreated (thick line) and TSP-treated (filled grey) cells. The bar
graph shows mean fluorescence intensity (MFI) of CCR7 staining. TSP-1 treatment significantly decreased the expression of CCR7
(* p<0.05).
doi: 10.1371/journal.pone.0075937.g005
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patients with KCS [9]. Despite appearing normal at birth, TSP-1
deficient mice progressively develop a chronic form of ocular
surface disease with age. In this study we report that, as in SS,
inflammatory damage in TSP-1 null mice is detected in the
conjunctiva (in addition to the lacrimal gland and cornea as
reported previously). This observation is supported by the
tissue expression of inflammatory cytokines, the appearance of
inflammatory infiltrates, the presence of increased lymphatic
vessels and inflammatory Th1 and Th17 effectors as well as
the loss of secretory function of mucin secreting goblet cells in
TSP-1 null conjunctiva.
In patients with SS, abnormalities of lacrimal gland secretion
compromise the protective function of tears, which in turn can
affect tissues of the ocular surface, cornea and conjunctiva.
Alterations in the morphology of epithelial cells in both of these
tissues are noted in SS subjects [6,7,29]. Damage to epithelial
cells of the cornea is reflected in a loss of their barrier function
detectable by increased fluorescein staining [30]. Similarly,
changes in ultrastructural morphology of apical conjunctival
epithelial cells are reported in Sjögren’s patients [8]. The
damage to conjunctival epithelium in SS also highlights an
importance of the glycocalyx (mucin) layer in tears that protects
the ocular surface from abrasions during lid movements. Our
observations in TSP-1 null mice are consistent with these
findings in that we note a metaplasia of conjunctival epithelial
cells which is accompanied with reduced tear mucin levels as
reported in SS patients [31].
The improved ocular signs in SS patients in response to anti-
inflammatory treatment have supported a role of inflammation
in the ocular surface damage seen in these patients [30]. In
addition to histopathological changes the presence of
inflammatory infiltrates was reported in the conjunctival
biopsies of SS patients [6,21]. These infiltrates included
neutrophils as well as lymphocytes with a predominance of T
cells. Similar findings were also reported by evaluating
conjunctival impression cytology specimens from SS patients
[32]. Impression cytology represents a non- or minimally
invasive biopsy of the ocular surface epithelium [33] that allows
assessment of goblet cell density in addition to the cytologic
features of the conjunctiva. Overexpression of several
inflammatory markers were reported in conjunctival cells from
impression cytology specimens of SS patients and these
changes were also correlated with a significant decrease in
goblet cells [34,35]. Thus it is believed that cytological changes
in the conjunctiva of SS patients are likely due to increased
expression of inflammatory mediators such as IL-6, IL-8, TNF-α
and TGF-β1 [22,23]. However, the inflammatory effectors
infiltrating the conjunctiva of SS patients are not yet as well
characterized as those from the lacrimal glands. In TSP-1 null
conjunctiva we detected increased expression of inflammatory
cytokines associated with Th1 (IFN-γ and TNF-α) as well as
Th17 (IL-6 and IL-17A) effectors and expression of these
cytokines progressively increased with age. The presence of
inflammatory mediators in TSP-1 null conjunctiva not only
correlated with the abnormalities of the conjunctival epithelial
cells but also with reduced goblet cell density as reported
previously [9]. However, the source of the detected cytokines is
not limited to adaptive immune cells as innate immune cells
such as natural killer (NK), NKT or gamma delta T cells
capable of producing these cytokines are also present in
normal mouse conjunctiva [36,37]. It is quite likely that altered
tear quality in TSP-1 null mice allows commensal microflora on
the ocular surface to activate innate cells to produce
proinflammatory cytokines. We also assessed the expression
of transcription factors that are typically associated with Th1
(Tbet) and Th17 (RORγt) effectors (both in the conjunctiva and
CLNs) and noted their significantly increased expression in the
TSP-1 null conjunctiva at all ages while in CLNs after 8 weeks
of age. However more recent reports indicate that in mucosal
tissues NK cells or their subset are capable of expressing
these transcription factors [38-40] although the presence of
such a population in the conjunctiva is yet to be established.
Since RORγt+ innate cells are rare in the peripheral lymph
nodes our results suggest a more likely increase in Th1 and
Th17 effectors in the CLNs of TSP-1 null mice, however a
possible recruitment of NK cells to the draining lymph nodes as
a part of an inflammatory response in these mice cannot be
ruled out.
The presence of inflammatory effectors in the CLNs of TSP-1
null mice is consistent with the autoimmune pathology reported
in these mice. Absence of these effectors at the age of 6 weeks
and their detection from 8 weeks onwards suggests a
possibility of sensitization to autoantigens during the interval of
6-8 weeks. Autoantigens derived from the ocular surface are
likely presented during this period by mature DCs derived from
inflamed conjunctiva. Increased inflammatory effectors in
TSP-1 null conjunctiva and CLNs correlated with increased
lymphatic vessels detectable in the conjunctiva, further
suggesting the possibility of an enhanced egress of antigen-
bearing DCs to the draining lymph nodes in TSP-1 null mice.
This possibility is further supported by a previous report of
significantly increased expression of CCR7, a draining lymph
node homing receptor, by TSP-1 null DCs [27] and our results
of in vitro inhibition of CCR7 in WT DCs by exogenous TSP-1.
In this study we further provide in vivo evidence for such TSP-
dependent regulation of DC migration from the ocular surface
to the draining LNs. The antilymphangiogenic role of TSP-1 is
also likely to contribute to such regulation [13]. Therefore,
collectively, our results indicate that the exposure of DCs to
TSP-1 in the tissue can prevent peripheral sensitization against
tissue-derived autoantigens.
Interestingly a decline in Foxp3+ Tregs in the cervical CLNs
of TSP-1 null mice was detectable at 12 weeks of age while
such a decline in the spleen was previously reported at 8
weeks of age [9]. The reasons behind this difference and the
earliest detection of Treg decline warrants further investigation.
However, a decline in peripheral Treg population concomitant
with an increase in inflammatory effectors is consistent with the
autoimmune pathogenesis of the inflammatory changes in
TSP-1 null mice. These observations can also be explained by
the compromised ability of TSP-1 null APCs to induce Foxp3+
Tregs as detected in our in vitro experiments (Mir, F. et al.,
manuscript submitted).
Thus our results shed light on possible immunologic
mechanisms that contribute to the development of autoimmune
SS. Similar to the lacrimal gland in TSP-1 null mice, the loss of
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secretory function of goblet cells in the conjunctiva appeared
prior to its infiltration by inflammatory cells detectable by
histology. However, innate cells resident in the conjunctiva are
capable of responding to microbial stimuli from the ocular
surface resulting in an inflammatory cytokine milieu that
interferes with goblet cell function and promotes DC migration.
In addition to shared epitopes between ocular tissues and the
lacrimal gland [41] the common draining lymph nodes between
these tissues likely generate a closely related immune
response. Our observations in TSP-1 null mice indicate that the
inflammatory processes at the ocular surface and lacrimal
gland are temporally distinct, presumably due to greater
vulnerability of the former tissue to pathogens. The decreased
tear MUC5AC levels further alter the barrier against pathogens
amplifying the local inflammatory process. Autoantigens
derived from the damaged ocular surface are readily presented
by local DCs to activate inflammatory effectors in the draining
LNs, which target ocular surface tissue to contribute further to
an ongoing inflammation and related tissue damage.
In conclusion, this study demonstrates that TSP-1 deficient
mice develop inflammation in the conjunctiva and have
reduced goblet cell secretion similar to that seen in patients
with SS. This model provides a better understanding of the
disease, allowing the investigation of SS development in ways
that would be inaccessible in a human patient. Furthermore our
results suggest that the anti-inflammatory and anti-
lymphangiogenic properties of TSP-1 contribute to the
regulation of an autoimmune response. Thus TSP-1 holds a
strong therapeutic potential in the treatment of ocular surface
inflammation associated with autoimmune SS.
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